Evidence map›Paper›PMID 34319135›Full record

ArticleMicrobiology spectrum2021

Rapid Detection of PBP2a in Staphylococci from Shortly Incubated Subcultures of Positive Blood Cultures by an Immunochromatographic Assay.

Natalia Kolesnik-Goldmann, Elias Bodendoerfer, Kim Röthlin, Sebastian Herren, Frank Imkamp, Martina Marchesi, Stefano Mancini

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Natalia Kolesnik-Goldmann *University of Zurichgrid.7400.3, Institute of Medical Microbiology, Zurich, Switzerland.
Elias Bodendoerfer *University of Zurichgrid.7400.3, Institute of Medical Microbiology, Zurich, Switzerland.
Kim RöthlinUniversity of Zurichgrid.7400.3, Institute of Medical Microbiology, Zurich, Switzerland.
Sebastian HerrenUniversity of Zurichgrid.7400.3, Institute of Medical Microbiology, Zurich, Switzerland.
Frank ImkampUniversity of Zurichgrid.7400.3, Institute of Medical Microbiology, Zurich, Switzerland.
Martina MarchesiUniversity of Zurichgrid.7400.3, Institute of Medical Microbiology, Zurich, Switzerland.
Stefano ManciniUniversity of Zurichgrid.7400.3, Institute of Medical Microbiology, Zurich, Switzerland.ORCID 0000-0003-4516-5952
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus aureus, as well as coagulase-negative staphylococci (CoNS), can cause a wide range of human infections both in nosocomial and community settings. Βeta-lactams are the antibiotics of choice for the treatment of bloodstream infections (BSI) caused by these microorganisms. Resistance to virtually all β-lactams (also referred to as methicillin resistance) primarily results from the production of an alternative penicillin-binding protein (PBP2a) encoded by the

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBlood CultureHumansImmunoassayMethicillin ResistancePathology, MolecularPenicillin-Binding ProteinsStaphylococcal InfectionsStaphylococcusStaphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsmecA protein, Staphylococcus aureusPenicillin-Binding Proteinsblood culturemethicillin resistanceMRSAPBP2arapid tests

Identifiers

PMID34319135
PMCPMC8552594
OpenAlexW3184037846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.